The pharmaceutical industry is unlike any other industry in that the products manufactured can dramatically improve, and even save, lives. This is especially the case when it comes to children. Although pediatric patients comprise a smaller population of pharmaceutical consumers, they have a greater need for products given the paucity of treatment options specifically for them. This two-part paper discusses the need for collaboration across the industry to ensure children get the medicines they need. Download to read Part One or click here to read Part Two.

Global Pediatric Drug Development Collaboration Part One

Explore related content and topics